» Articles » PMID: 6285406

Action of Cannabidiol on the Anxiety and Other Effects Produced by Delta 9-THC in Normal Subjects

Overview
Specialty Pharmacology
Date 1982 Jan 1
PMID 6285406
Citations 199
Authors
Affiliations
Soon will be listed here.
Abstract

The object of the experiment was to verify whether cannabidiol (CBD) reduces the anxiety provoked by delta 9-THC in normal volunteers, and whether this effect occurs by a general block of the action of delta 9-THC or by a specific anxiolytic effect. Appropriate measurements and scales were utilized and the eight volunteers received, the following treatments in a double-blind procedure: 0.5 mg/kg delta 9-THC, 1 mg/kg CBD, a mixture containing 0.5 mg/kg delta 9-THC and 1 mg/kg CBD and placebo and diazepam (10 mg) as controls. Each volunteer received the treatments in a different sequence. It was verified that CBD blocks the anxiety provoked by delta 9-THC, however this effect also extended to marihuana-like effects and to other subjective alterations induced by delta 9-THC. This antagonism does not appear to be caused by a general block of delta 9-THC effects, since no change was detected in the pulse-rate measurements. Several further effects were observed typical of CBD and of an opposite nature to those of delta 9-THC. These results suggest that the effects of CBD, as opposed to those of delta 9-THC, might be involved in the antagonism of effects between the two cannabinoids.

Citing Articles

Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer Treatment.

Taudul J, Celej J, Zelechowska-Matysiak K, Kepinska D, Majkowska-Pilip A, Strawski M Biomolecules. 2025; 15(2).

PMID: 40001533 PMC: 11853022. DOI: 10.3390/biom15020230.


Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health Claims.

Engeli B, Lachenmeier D, Diel P, Guth S, Villar Fernandez M, Roth A Nutrients. 2025; 17(3).

PMID: 39940347 PMC: 11820564. DOI: 10.3390/nu17030489.


Oral cannabidiol did not impair learning and memory in healthy adults.

Gebregzi H, Zeiger J, Smith J, Stuyt L, Cullen L, Carsella J J Cannabis Res. 2025; 7(1):5.

PMID: 39849639 PMC: 11756171. DOI: 10.1186/s42238-025-00262-2.


Potential Risks from Cannabis-Infused Beverages: A Critical Review.

Froude A, Pangborn N, Britz-McKibbin P, MacKillop J, Balodis I Cannabis. 2025; 7(3):134-166.

PMID: 39781553 PMC: 11705039. DOI: 10.26828/cannabis/2024/000271.


Research and Clinical Practice Involving the Use of Products, with Emphasis on Cannabidiol: A Narrative Review.

Simei J, Souza J, Pedrazzi J, Guimaraes F, Campos A, Zuardi A Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770486 PMC: 11677192. DOI: 10.3390/ph17121644.


References
1.
Klapper J, McColloch M, Sidell F . The effect on personality of reactivity to 1,2-dimethyl-heptyl tetrahydrocannabinol. Arch Gen Psychiatry. 1972; 26(5):483-5. DOI: 10.1001/archpsyc.1972.01750230093018. View

2.
KIPLINGER G, Manno J, Rodda B, FORNEY R . Dose-response analysis of the effects of tetrahydrocannabinol in man. Clin Pharmacol Ther. 1971; 12(4):650-7. DOI: 10.1002/cpt1971124650. View

3.
Bech P, Rafaelsen L, Rafaelsen O . Cannabis: a psychopharmacological review. Dan Med Bull. 1974; 21(3):106-20. View

4.
Fernandes M, Schabarek A, Coper H, Hill R . Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat. Psychopharmacologia. 1974; 38(4):329-38. DOI: 10.1007/BF00429130. View

5.
Davis W, Borgen L . Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior. Res Commun Chem Pathol Pharmacol. 1974; 9(3):453-62. View